E.V.A Biosystems

Biological additives for plastic manufacturers to make conventional plastics selectively degradable in target environments

Edinburgh, United KingdomFounded 2021evabiosystems.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-13

About E.V.A Biosystems

E.V.A Biosystems is developing biological additives that embed microbes in conventional plastics, initially focusing on PET. The microbes are designed to respond to selected environmental signals and produce enzymes that break down the polymer.

The company works with industry on additives intended for existing manufacturing processes, including injection moulding. Its technology is in development and is not yet commercially available.

E.V.A Biosystems Limited was founded in 2021 and is headquartered in Edinburgh, UK. Its work has included prototype development and manufacturing development with the National Manufacturing Institute Scotland.

Product: Biological additives for conventional plastics, initially focused on PET, designed to trigger polymer breakdown in selected environments.

Jobs at E.V.A Biosystems

No open positions listed right now.

More biotech & pharma companies

  • Earlham Enterprises

    Contract research and genomics services for academic, public-sector, nonprofit and private organisations
    Norwich, United KingdomBiotech & pharmaFounded 2009
  • Eco Animal Health

    Veterinary medicines and vaccines for pig, poultry and cattle producers, sold directly and through distributors in over 70 countries
    London, United KingdomBiotech & pharmaFounded 1991
    New on Evolc
  • Ecotype Genetics

    DNA testing and species identification services for ecologists, conservation groups and environmental researchers in the UK
    Hove, United KingdomBiotech & pharmaFounded 2018
    New on Evolc
  • Elasmogen

    Biopharma developing ELN28, a dual-acting TNFα and JAK inhibitor conjugate for hidradenitis suppurativa patients
    Foresterhill, United KingdomBiotech & pharmaFounded 2014
  • Elastrin Therapeutics

    Antibody-targeted nanoparticle therapies for patients with vascular calcification and cardiovascular disease
    Wantage, United KingdomBiotech & pharmaFounded 2022
    Young companyNew on Evolc
  • Eleventx

    Extended-release RNA medicines for chronic disease, starting in cardiometabolic, developed with pharma partners
    Cambridge, United KingdomBiotech & pharma2 open jobs

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Hosting

  • nginxHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.